Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Miyoshi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Diabetes Investigation|October 19, 2021
Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trialShinnosuke Hata, Hanako Nakajima, Yoshitaka Hashimoto, et al.
Nutrition & Metabolism|July 28, 2022
Inulin reduces visceral adipose tissue mass and improves glucose tolerance through altering gut metabolitesHanako Nakajima, Naoko Nakanishi, Tomoki Miyoshi, et al.
Nutrients|September 9, 2022
Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db MiceShinnosuke Hata, Takuro Okamura, Ayaka Kobayashi, et al.
Journal of the Endocrine Society|January 12, 2024
Association of Elevated Serum Branched-chain Amino Acid Levels With Longitudinal Skeletal Muscle LossDan Imai, Naoko Nakanishi, Natsuko Shinagawa, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Diabetes Investigation|October 19, 2021
Effects of probiotic Bifidobacterium bifidum G9-1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trialShinnosuke Hata, Hanako Nakajima, Yoshitaka Hashimoto, et al.
Nutrition & Metabolism|July 28, 2022
Inulin reduces visceral adipose tissue mass and improves glucose tolerance through altering gut metabolitesHanako Nakajima, Naoko Nakanishi, Tomoki Miyoshi, et al.
Nutrients|September 9, 2022
Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db MiceShinnosuke Hata, Takuro Okamura, Ayaka Kobayashi, et al.
Journal of the Endocrine Society|January 12, 2024
Association of Elevated Serum Branched-chain Amino Acid Levels With Longitudinal Skeletal Muscle LossDan Imai, Naoko Nakanishi, Natsuko Shinagawa, et al.
Pageof 2